-
Signature
-
Janet Lee, Attorney-in-Fact
-
Stock symbol
-
ANSS
-
Transactions as of
-
Jul 18, 2023
-
Transactions value $
-
-$6,209,442
-
Form type
-
4
-
Date filed
-
7/20/2023, 05:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ANSS |
Common Stock |
Options Exercise |
$1.26M |
+13.3K |
+6.2% |
$95.09 |
227K |
Jul 18, 2023 |
Direct |
|
transaction |
ANSS |
Common Stock |
Sale |
-$4.64M |
-13.3K |
-5.84% |
$350.04 |
214K |
Jul 18, 2023 |
Direct |
F1, F2 |
transaction |
ANSS |
Common Stock |
Options Exercise |
$1.05M |
+11.1K |
+5.18% |
$95.09 |
225K |
Jul 19, 2023 |
Direct |
|
transaction |
ANSS |
Common Stock |
Sale |
-$3.71M |
-10.6K |
-4.7% |
$350.15 |
214K |
Jul 19, 2023 |
Direct |
F1, F3 |
transaction |
ANSS |
Common Stock |
Sale |
-$176K |
-500 |
-0.23% |
$351.04 |
214K |
Jul 19, 2023 |
Direct |
F1, F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ANSS |
Option To Purchase |
Options Exercise |
$0 |
-13.3K |
-8.47% |
$0.00 |
143K |
Jul 18, 2023 |
Common Stock |
13.3K |
$95.09 |
Direct |
F6 |
transaction |
ANSS |
Option to Purchase |
Options Exercise |
$0 |
-11.1K |
-7.73% |
$0.00 |
132K |
Jul 19, 2023 |
Common Stock |
11.1K |
$95.09 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: